ADMA (ADMA Biologics) Shiller PE Ratio: (As of Sep. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADMA ADMA Biologics Inc ADMA
64 GF Score
Price $9.54
GF Value $18.30
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is ADMA Biologics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


ADMA Biologics  (NAS:ADMA) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


ADMA Biologics Shiller PE Ratio Related Terms


ADMA Biologics Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for ADMA Biologics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ADMA Biologics Shiller PE Ratio Chart

ADMA Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ADMA Biologics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ADMA vs VCEL, COAG, KLRA: Shiller PE Ratio Comparison

For the Biotechnology subindustry, ADMA Biologics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ADMA Biologics Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ADMA Biologics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where ADMA Biologics's Shiller PE Ratio falls into.


ADMA
64GF Score
ADMA Biologics Inc ADMA
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ADMA Biologics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

ADMA Biologics's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, ADMA Biologics's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.16/333.9520*333.9520
=0.160

Current CPI (Jun. 2026) = 333.9520.

ADMA Biologics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -0.340 241.428 -0.470
201612 -0.350 241.432 -0.484
201703 -0.510 243.801 -0.699
201706 -0.550 244.955 -0.750
201709 -0.590 246.819 -0.798
201712 -0.286 246.524 -0.387
201803 -0.390 249.554 -0.522
201806 -0.350 251.989 -0.464
201809 -0.330 252.439 -0.437
201812 -0.390 251.233 -0.518
201903 -0.280 254.202 -0.368
201906 -0.250 256.143 -0.326
201909 -0.190 256.759 -0.247
201912 -0.180 256.974 -0.234
202003 -0.260 258.115 -0.336
202006 -0.230 257.797 -0.298
202009 -0.190 260.280 -0.244
202012 -0.200 260.474 -0.256
202103 -0.160 264.877 -0.202
202106 -0.150 271.696 -0.184
202109 -0.130 274.310 -0.158
202112 -0.090 278.802 -0.108
202203 -0.130 287.504 -0.151
202206 -0.070 296.311 -0.079
202209 -0.080 296.808 -0.090
202212 -0.060 296.797 -0.068
202303 -0.030 301.836 -0.033
202306 -0.030 305.109 -0.033
202309 0.010 307.789 0.011
202312 -0.080 306.746 -0.087
202403 0.080 312.332 0.086
202406 0.130 314.175 0.138
202409 0.150 315.301 0.159
202412 0.460 315.605 0.487
202503 0.110 319.799 0.115
202506 0.140 322.561 0.145
202509 0.150 324.800 0.154
202512 0.200 324.054 0.206
202603 0.190 330.213 0.192
202606 0.160 333.952 0.160

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is ADMA Biologics (ADMA) Overvalued in 2026?

Based on GuruFocus' analysis, ADMA Biologics stock appears to be undervalued. The current stock price of $9.54 is trading 47.9% below its estimated GF Value™ of $18.30. GuruFocus considers ADMA Biologics to be Significantly Undervalued.

Key valuation signals for ADMA:

  • Shiller PE Ratio:
  • GF Value™: $18.30 vs. price of $9.54 (47.9% below fair value)
  • GF Score™: 64/100 with 2 warning signs

No single metric tells the full story. See the ADMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ADMA Biologics Business Description

Address 465 State Route 17, Ramsey, NJ, USA, 07446
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
64GF Score

Get the complete analysis for ADMA

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.54
Price
$18.30
GF Value